Astrazeneca has a market cap of 177.38 Billion USD which is a 99.32% higer valuation than Kymera Therapeutics
Astrazeneca has a 99.87% higer revenue than Kymera Therapeutics, the last quarter (Year to year) Astrazeneca revenue is up 31% and Kymera Therapeutics is down -37.8%
We are missing info about Kymera Therapeutics's profit
We are missing info about Astrazeneca's P/E Ratio
Astrazeneca's price to sale ratio is 81.18% lower than Kymera Therapeutics's
AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections, neuroscience and gastroenterology worldwide.
The company is headquartered in Cambridge, the United Kingdom.
Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down disease-causing proteins by harnessing the body's own natural protein breakdown system.
The company is headquartered in Watertown, Massachusetts.
The best Cash App card designs are the ones that inspire creativity. You can use a variety of designs and emojis to make your card stand out. You can be …Read More
Do you struggle to give meaningful gifts to friends and family? Sometimes, it is easiest just to allow them to purchase their own present by gracing them with gift cards. …Read More
Cash App is an incredibly convenient online bank that allows you to transfer money between users with no fees. Not only that, but you can spend all the money in …Read More